Aggarwal, said that they believe the shortage could last significantly longer
GLP-1 Medications for Weight Loss: Semaglutide, Tirzepatide, and Retatrutide Compared The landscape of obesity treatment has shifted dramatically over the past decade, thanks to a class of medications known as GLP-1 receptor agonists
After months of steady progress, some researchers find that tirzepatide stops producing weight loss even at maximum doses
However, long-term risks such as rare adverse effects, metabolic effects over years, effects on bone, gallbladder, and pancreas need phase-3 trials and post-marketing surveillance to ensure the medication is safe for long-term use
Patients should contact a clinician if they cannot keep fluids down, have very dark urine, feel faint, or develop persistent vomiting or diarrhea
Common side effects of retatrutide include nausea, vomiting, constipation, fatigue, diarrhea, headaches, and abdominal discomfort